Inventor · Tampa, FL, US

Jin Q. Cheng

37Patents
4h-index
13Co-inventors
56Inventor score

Filing activity: Mar 29, 2005 → Apr 14, 2017

Most-cited inventions

PatentTitleAreaCited byStatus
US9410956B1 Micro-RNA profiling in ovarian cancer Chemistry; Metallurgy 11 Active
US8435959B2 Effective treatment of tumors and cancer with triciribine and related compounds Human Necessities 10 Expired
US8183249B2 Inhibitors of AKT/PKB with anti-tumor activity Chemistry; Metallurgy 7 Active
US8435550B2 Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device Human Necessities 4 Active
US8828451B2 Akt sensitization of cancer cells Chemistry; Metallurgy 2 Active
US9453049B2 Substrate-mimetic Akt inhibitor Chemistry; Metallurgy 1 Active
US9498492B2 Compositions including triciribine and taxanes and methods of use thereof Physics 1 Active
US9115162B2 Effective treatment of tumors and cancer with triciribine and related compounds Human Necessities 1 Active
US8901086B2 Compositions including triciribine and methods of use thereof Human Necessities 1 Active
US9511084B2 Compositions including triciribine and methods of use thereof Chemistry; Metallurgy 1 Active
US8822524B2 Substrate-mimetic Akt inhibitor Chemistry; Metallurgy 1 Active
US8623834B2 Compositions including triciribine and trastuzumab and methods of use thereof Chemistry; Metallurgy 1 Active
US9655914B2 Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof Physics 0 Active
US8865666B2 Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof Human Necessities 0 Active
US9192645B2 Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof Human Necessities 0 Active
US9433635B2 Effective treatment of ovarian cancer using triciribine and related compounds Physics 0 Active
US10780104B2 Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof Physics 0 Active
US10744148B2 Methods of treating breast cancer that overexpress AKT kinase Physics 0 Active
US9486492B2 Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof Human Necessities 0 Active
US8906869B2 Effective treatment of ovarian cancer using triciribine and related compounds Physics 0 Active
US8673868B2 Compositions including triciribine and one or more platinum compounds and methods of use thereof Physics 0 Active
US9186403B2 Compositions including triciribine and trastuzumab and methods of use thereof Chemistry; Metallurgy 0 Active
US9211299B2 Compositions including triciribine and one or more platinum compounds and methods of use thereof Physics 0 Active
US8178502B2 Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds Physics 0 Active
US9101641B2 Compositions including triciribine and taxanes and methods of use thereof Physics 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.